Trials / Recruiting
RecruitingNCT06717412
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy: A Multicenter, Prospective, Randomized, Double-blind, Non-inferiority Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 146 (estimated)
- Sponsor
- Wang Yusheng · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Evaluating the Optimal Effective Dose and Safety of Conbercept in Treating Retinopathy of Prematurity (ROP)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Conbercept | Administered as an intravitreal injection |
Timeline
- Start date
- 2024-11-29
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2024-12-05
- Last updated
- 2025-04-04
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06717412. Inclusion in this directory is not an endorsement.